665 related articles for article (PubMed ID: 16816005)
1. Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.
Klein KC; Blackwood RA
Pediatrics; 2006 Aug; 118(2):e506-8. PubMed ID: 16816005
[TBL] [Abstract][Full Text] [Related]
2. Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.
Santos RP; Sánchez PJ; Mejias A; Benjamin DK; Walsh TJ; Patel S; Jafri HS
Pediatr Infect Dis J; 2007 Apr; 26(4):364-6. PubMed ID: 17414408
[TBL] [Abstract][Full Text] [Related]
3. Voriconazole for the treatment of disseminated nodular cutaneous aspergillosis in a patient affected by acute myeloid leukemia.
La Nasa G; Littera R; Maccioni A; Ledda A; Vacca A; Contu L
Hematol J; 2004; 5(2):178-80. PubMed ID: 15048069
[TBL] [Abstract][Full Text] [Related]
4. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
[TBL] [Abstract][Full Text] [Related]
5. Successful combined antifungal salvage therapy with liposomal amphothericin B and caspofungin for invasive Aspergillus flavus infection in a child following allogeneic bone marrow transplantation.
Kriván G; Sinkó J; Nagy IZ; Goda V; Reményi P; Bátai A; Lueff S; Kapás B; Réti M; Tremmel A; Masszi T
Acta Biomed; 2006; 77 Suppl 2():17-21. PubMed ID: 16918062
[TBL] [Abstract][Full Text] [Related]
6. Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
Mattei D; Mordini N; Lo Nigro C; Ghirardo D; Ferrua MT; Osenda M; Gallamini A; Bacigalupo A; Viscoli C
Bone Marrow Transplant; 2002 Dec; 30(12):967-70. PubMed ID: 12476292
[TBL] [Abstract][Full Text] [Related]
7. Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight.
Frankenbusch K; Eifinger F; Kribs A; Rengelshauseu J; Roth B
J Perinatol; 2006 Aug; 26(8):511-4. PubMed ID: 16871222
[TBL] [Abstract][Full Text] [Related]
8. [Experience with voriconazole in invasive aspergillosis].
Thiel E; Schwartz S
Mycoses; 2003; 46 Suppl 2():3-7. PubMed ID: 15055137
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous aspergillosis in an immunocompetent patient: successful treatment with oral voriconazole.
Craiglow B; Hinds G; Antaya R; Girardi M
Pediatr Dermatol; 2009; 26(4):493-5. PubMed ID: 19689543
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of brain aspergillosis with voriconazole.
Tattevin P; Bruneel F; Lellouche F; de Broucker T; Chevret S; Wolff M; Régnier B
Clin Microbiol Infect; 2004 Oct; 10(10):928-31. PubMed ID: 15373890
[TBL] [Abstract][Full Text] [Related]
11. Case report: Invasive aspergillosis successfully treated with voriconazole without recurrence during subsequent bone marrow transplantation.
Chow E; Moore T; Nielsen K
Pediatr Infect Dis J; 2003 Dec; 22(12):1109-10. PubMed ID: 14688580
[TBL] [Abstract][Full Text] [Related]
12. [Aspergillus tracheobronchitis in a lung transplant recipient].
García-Gallo CL; García-Fadul C; Laporta-Hernández R; Ussetti-Gil P
Rev Iberoam Micol; 2011; 28(3):129-33. PubMed ID: 21700233
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of primary cutaneous Aspergillus ustus infection with surgical debridement and a combination of voriconazole and terbinafine.
Krishnan-Natesan S; Chandrasekar PH; Manavathu EK; Revankar SG
Diagn Microbiol Infect Dis; 2008 Dec; 62(4):443-6. PubMed ID: 18842377
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous aspergillosis in a lung transplant recipient.
Ramos A; Ussetti P; Laporta R; Lázaro MT; Sánchez-Romero I
Transpl Infect Dis; 2009 Oct; 11(5):471-3. PubMed ID: 19622116
[TBL] [Abstract][Full Text] [Related]
15. Invasive cutaneous mucormycosis caused by Absidia corymbifera after allogeneic bone marrow transplantation.
Jantunen E; Kolho E; Ruutu P; Koukila-Kähkölä P; Virolainen M; Juvonen E; Volin L
Bone Marrow Transplant; 1996 Jul; 18(1):229-30. PubMed ID: 8832023
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma.
Stiefel M; Reiss T; Staege MS; Rengelshausen J; Burhenne J; Wawer A; Foell JL
Pediatr Blood Cancer; 2007 Aug; 49(2):203-7. PubMed ID: 16333861
[TBL] [Abstract][Full Text] [Related]
17. Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.
Wieland T; Liebold A; Jagiello M; Retzl G; Birnbaum DE
J Heart Lung Transplant; 2005 Jan; 24(1):102-4. PubMed ID: 15653389
[TBL] [Abstract][Full Text] [Related]
18. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Sambatakou H; Dupont B; Lode H; Denning DW
Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
[TBL] [Abstract][Full Text] [Related]
19. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
[TBL] [Abstract][Full Text] [Related]
20. [Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy].
Ozçelik T; Ozkalemkaş F; Kocaeli H; Altundal Y; Ener B; Ali R; Ozkocaman V; Hakyemez B; Tunali A
Mikrobiyol Bul; 2009 Jul; 43(3):499-506. PubMed ID: 19795628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]